Fibroblast Growth Factor 23 and Cardiovascular Disease in Patients With Chronic Kidney Disease

Renal Replacement Therapy
doi 10.1186/s41100-018-0172-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

JAMA - Journal of the American Medical Association
Medicine
2011English

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE

Circulation
Cardiovascular MedicinePhysiologyCardiology
2015English

Fibroblast Growth Factor 23 Is Upregulated in the Kidney in a Chronic Kidney Disease Rat Model

PLoS ONE
Multidisciplinary
2018English

Regulation of Fibroblast Growth Factor 23 ( FGF 23) in Health and Disease

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2019English

Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population: The Multi-Ethnic Study of Atherosclerosis

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2014English

Assessment of Urinary Epidermal Growth Factor Level in Patients With Chronic Kidney Disease

Urology & Nephrology Open Access Journal
2018English

Fibroblast Growth Factor (FGF)23 in Patients With Acromegaly

Endocrine Journal
EndocrinologyMetabolismDiabetes
2007English

Cardiovascular Risks in Chronic Kidney Disease Pediatric Patients (Review)

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy